Holdings
Acorn Capital Advisors, LLC
As of Jun 30, 2026, Acorn Capital Advisors, LLC reported 17 positions worth US$302M. Largest: Cg Oncology, Inc., Trevi Therapeutics, Inc. and Candel Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cg Oncology, Inc. | 1.13M | US$80.4M | +999 | Jun 30, 2026 |
| Trevi Therapeutics, Inc. | 2.14M | US$40M | no change | Jun 30, 2026 |
| Candel Therapeutics, Inc. | 3.5M | US$36M | no change | Jun 30, 2026 |
| Puma Biotechnology Inc | 4.13M | US$33.5M | no change | Jun 30, 2026 |
| Jade Biosciences, Inc. | 987K | US$21.9M | +200K | Jun 30, 2026 |
| Bicara Therapeutics Inc. | 643K | US$19.1M | −1 | Jun 30, 2026 |
| Karyopharm Therapeutics Inc. | 1.52M | US$14.8M | +1.23M | Jun 30, 2026 |
| Onkure Therapeutics, Inc. | 2.84M | US$12.9M | no change | Jun 30, 2026 |
| Cybin, Inc. | 1.54M | US$10.2M | no change | Jun 30, 2026 |
| Protara Therapeutics, Inc. | 1.75M | US$6.69M | no change | Jun 30, 2026 |